tiprankstipranks
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
Holding AKRO?
Track your performance easily

Akero Therapeutics (AKRO) Ownership - Who Owns Akero Therapeutics?

472 Followers

Akero Therapeutics (AKRO) Ownership Overview

3.27%25.40%44.09%12.97%14.27%
44.09% Other Institutional Investors
12.97% ETFs
14.27% Public Companies and
Individual Investors
The ownership structure of Akero Therapeutics (AKRO) stock is a mix of institutional, retail, and individual investors. Approximately 82.46% of the company’s stock is owned by Institutional Investors, 3.27% is owned by Insiders, and 14.27% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 13, 2024
xxxxxxxxxxxxx
$16677
Sep 13, 2024
Andrew Cheng
President & Ceo,director
xxxxxxxxxxxxx
$45501
Sep 13, 2024
xxxxxxxxxxxxx
$14870
Sep 13, 2024
xxxxxxxxxxxxx
$16729

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$384331
Sep 30, 2024
xxxxxxxxxxxxx
$8390906
Sep 30, 2024
xxxxxxxxxxxxx
$49197784

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,487,403Institution5.00%108,806,974
3,136,685Institution4.49%97,864,572
2,970,761Institution4.26%92,687,743
2,508,425Institution3.59%78,262,860
2,321,101Institution3.33%72,418,351
1,995,635Institution2.86%62,263,812
1,714,806Institution2.46%53,501,947
1,097,082Institution1.57%34,228,958
1,094,238Institution1.57%34,140,226
802,168Insider1.15%25,027,642

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,970,761Institution4.26%92,687,743
2,508,425Institution3.59%78,262,860
2,321,101Institution3.33%72,418,351
1,995,635Institution2.86%62,263,812
753,408Institution1.08%23,506,330
732,719Institution1.05%22,860,833
722,363Institution1.03%22,537,726
542,464Institution0.78%16,924,877
470,835Institution0.67%14,690,052
450,880Institution0.65%14,067,456

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,926,204Institution2.76%59,384,869
1,845,741Institution2.64%57,587,119
955,892Institution1.37%29,470,150
960,682Institution1.38%29,430,493
546,176Institution0.78%17,040,691
403,744Institution0.58%12,596,813
309,075Institution0.44%9,528,782
306,540Institution0.44%9,390,853
228,454Institution0.33%6,998,688
160,953Institution0.23%4,962,181

FAQ

Who Owns Akero Therapeutics Inc (AKRO)?
According to the latest TipRanks data, approximately 44.09% of the company's stock is held by institutional investors, 3.27% is held by insiders, and 14.27% is held by retail investors.
    What percentage of Akero Therapeutics Inc (AKRO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 44.09% of Akero Therapeutics Inc (AKRO) stock is held by institutional investors.
      What percentage of Akero Therapeutics Inc (AKRO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 14.27% of Akero Therapeutics Inc (AKRO) stock is held by retail investors.
        Who owns the most shares of Akero Therapeutics Inc (AKRO)?
        Vanguard owns the most shares of Akero Therapeutics Inc (AKRO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis